Pharma is opening the doors for external molecule designers
The Open Innovation model is being explored by Pharma and it holds great promise for all parties in the Life Science ecosystem. In a move to further boost early drug discovery innovation several OI platforms in Pharma RnD have been established in order to allow external partner to much more easily test their molecules for biological activity.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.